Hematology NewsEurope approves first gene therapy for hemophilia BFebruary 27, 2023Bleeding DisordersGene Therapy
Hematology NewsBeta-thalassemia: Benefits of gene therapy outweigh costsDecember 14, 2022Bleeding DisordersTransfusion MedicineGene Therapy
Hematology NewsPricey gene therapy looks cost-effective for SCDDecember 13, 2022Gene TherapyAnemiaMixed Topics
Hematology NewsFDA approves first gene therapy for hemophilia BNovember 22, 2022Bleeding DisordersGene Therapy
Hematology News‘Superior’ CLL regimen cuts chemo in halfJune 28, 2022CLLCellular TherapyMixed TopicsGene TherapyMyelodysplastic SyndromeAML
Hematology NewsFDA approves liso-cel as second-line therapy for LBCLJune 27, 2022B Cell LymphomaMixed TopicsCellular TherapyGene TherapyCLL
Hematology NewsNovel gene therapy offers hope for some lymphomasJune 9, 2022B Cell LymphomaGene TherapyTransplantMixed Topics
Hematology News‘Exciting’ new gene therapy yields promising resultsJune 5, 2022Gene TherapyIndolent LymphomaB Cell Lymphoma
Hematology News‘Very impressive’ data promise new blood cancer optionJune 5, 2022Multiple MyelomaGene Therapy
Hematology News'New benchmark' set in phase-3 blood cancer studyJune 3, 2022Mantle Cell LymphomaGene Therapy
Hematology NewsFirst-line CAR T-cell therapy could help cure some lymphomasMarch 22, 2022Aggressive LymphomasDLBCLGene Therapy
Hematology NewsGene therapy for hemophilia A: `Truly transformative and liberating’March 17, 2022Bleeding DisordersGene Therapy
Hematology NewsGene therapy: A ‘one and done’ hemophilia B treatment?February 17, 2022Bleeding DisordersGene Therapy
Hematology NewsNew hemophilia treatments: ‘Our cup runneth over’February 15, 2022Bleeding DisordersGene TherapyThrombosis
